Ann: New Biochip gFET design sent to foundry partner in Spain, page-10

Slowly slowly but it’s ok if they get it right. I’m hopeful timing in the small cap tech space is more optimistic than say biotech. The likelihood of quick progress here might be better but who knows, it’s newish territory. The fact that this Spanish company can validate the biochip and they deal with other pharma is a positive for Archer in terms of knowledge exchange. The money to set up foundries is pretty huge, so to have relationships already with 3 in Europe is pretty good IMO. Not bullish on SP yet but given the complexity, many won’t take interest until the price probably rises significantly. GLTA